Targeted Metagenomics for Clinical Detection and Discovery of Bacterial Tick-Borne Pathogens.

Lyme disease anaplasmosis human granulocytic ehrlichiosis metagenomics tick-borne bacteria vector-borne diseases

Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
21 10 2020
Historique:
received: 23 01 2020
accepted: 21 07 2020
pubmed: 4 9 2020
medline: 24 6 2021
entrez: 4 9 2020
Statut: epublish

Résumé

Tick-borne diseases, due to a diversity of bacterial pathogens, represent a significant and increasing public health threat throughout the Northern Hemisphere. A high-throughput 16S V1-V2 rRNA gene-based metagenomics assay was developed and evaluated using >13,000 residual samples from patients suspected of having tick-borne illness and >1,000 controls. Taxonomic predictions for tick-borne bacteria were exceptionally accurate, as independently validated by secondary testing. Overall, 881 specimens were positive for bacterial tick-borne agents. Twelve tick-borne bacterial species were detected, including two novel pathogens, representing a 100% increase in the number of tick-borne bacteria identified compared to what was possible by initial PCR testing. In three blood specimens, two tick-borne bacteria were simultaneously detected. Seven bacteria, not known to be tick transmitted, were also confirmed to be unique to samples from persons suspected of having tick-borne illness. These results indicate that 16S V1-V2 metagenomics can greatly simplify diagnosis and accelerate the discovery of bacterial tick-borne pathogens.

Identifiants

pubmed: 32878950
pii: JCM.00147-20
doi: 10.1128/JCM.00147-20
pmc: PMC7587092
pii:
doi:

Substances chimiques

RNA, Ribosomal, 16S 0

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, U.S. Gov't, P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 American Society for Microbiology.

Références

Emerg Infect Dis. 1998 Apr-Jun;4(2):179-86
pubmed: 9621188
Clin Infect Dis. 2018 Jun 1;66(12):1864-1871
pubmed: 29272385
Diagn Microbiol Infect Dis. 2012 Jul;73(3):243-5
pubmed: 22571973
J Clin Microbiol. 2002 Feb;40(2):690-3
pubmed: 11825999
Emerg Infect Dis. 2008 Mar;14(3):522-3
pubmed: 18325285
Clin Microbiol Rev. 2005 Jul;18(3):484-509
pubmed: 16020686
Lancet Infect Dis. 2016 May;16(5):556-564
pubmed: 26856777
Genome Biol. 2014 Mar 03;15(3):R46
pubmed: 24580807
N Engl J Med. 2018 Aug 23;379(8):701-703
pubmed: 30044925
Trop Med Infect Dis. 2018 Jan 29;3(1):
pubmed: 30274412
J Clin Microbiol. 2003 Dec;41(12):5492-9
pubmed: 14662930
Trends Parasitol. 2015 Nov;31(11):536-552
pubmed: 26458781
Can Vet J. 2013 Jun;54(6):565-72
pubmed: 24155447
N Engl J Med. 2011 Aug 4;365(5):422-9
pubmed: 21812671
Clin Microbiol Infect. 2011 Jan;17(1):69-79
pubmed: 20132258
Int J Syst Evol Microbiol. 2020 May;70(5):3577-3581
pubmed: 32320380
Trends Parasitol. 2018 Apr;34(4):295-309
pubmed: 29336985
Emerg Infect Dis. 2006 Nov;12(11):1799-801
pubmed: 17283646
Bioinformatics. 2011 Nov 1;27(21):2957-63
pubmed: 21903629
J Clin Microbiol. 2013 Jan;51(1):314-7
pubmed: 23135935
Clin Infect Dis. 2010 Feb 15;50(4):541-8
pubmed: 20073993
MMWR Morb Mortal Wkly Rep. 2018 May 04;67(17):496-501
pubmed: 29723166
Clin Infect Dis. 2014 Sep 1;59(5):676-81
pubmed: 24879782
Emerg Infect Dis. 2015 Sep;21(9):1625-31
pubmed: 26291194
Ticks Tick Borne Dis. 2018 Sep;9(6):1528-1531
pubmed: 30064965
Mol Biol Evol. 2016 Jul;33(7):1870-4
pubmed: 27004904
Emerg Infect Dis. 2015 Oct;21(10):1794-9
pubmed: 26402378
Am J Clin Pathol. 2020 Jan 1;153(1):139-145
pubmed: 31584611
BMC Bioinformatics. 2014 Nov 19;15:366
pubmed: 25408143
J Clin Microbiol. 1997 Nov;35(11):2715-27
pubmed: 9350721
Ann Intern Med. 2013 Jul 2;159(1):21-7
pubmed: 23817701
BMC Biol. 2014 Nov 12;12:87
pubmed: 25387460
Ticks Tick Borne Dis. 2010 Dec;1(4):159-67
pubmed: 21359090

Auteurs

Luke Kingry (L)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA vtx8@cdc.gov.

Sarah Sheldon (S)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Stephanie Oatman (S)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Bobbi Pritt (B)

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Melissa Anacker (M)

Minnesota Department of Health, St. Paul, Minnesota, USA.

Jenna Bjork (J)

Minnesota Department of Health, St. Paul, Minnesota, USA.

David Neitzel (D)

Minnesota Department of Health, St. Paul, Minnesota, USA.

Anna Strain (A)

Minnesota Department of Health, St. Paul, Minnesota, USA.

Jon Berry (J)

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Lynne Sloan (L)

Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.

Laurel Respicio-Kingry (L)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Elizabeth Dietrich (E)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Karen Bloch (K)

Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Abelardo Moncayo (A)

Tennessee Department of Health, Nashville, Tennessee, USA.

Ganesh Srinivasamoorthy (G)

Scientific Computing and Bioinformatics Support, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Bin Hu (B)

Scientific Computing and Bioinformatics Support, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Alison Hinckley (A)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Paul Mead (P)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Kiersten Kugeler (K)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Jeannine Petersen (J)

Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH